INCYTE CORPORATION Finance Lease, Right-of-Use Asset, after Accumulated Amortization
INCYTE CORPORATION (INCY) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $26.67 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-04-28
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $26.67M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $27.52M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $28.16M.
- 2025-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $29.00M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-03-31 | $26.67M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $27.52M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $28.16M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $29.00M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $29.89M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $30.80M 10-K · filed 2026-02-10 |
| 2024-09-30 | $25.07M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $25.54M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $25.53M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $25.54M 10-K · filed 2025-02-10 |
| 2023-09-30 | $24.88M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $25.63M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $25.85M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $26.30M 10-K · filed 2024-02-13 |
| 2022-09-30 | $26.68M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $27.35M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $27.39M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $27.55M 10-K · filed 2023-02-07 |
| 2021-09-30 | $27.13M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $27.68M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $27.99M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $28.45M 10-K · filed 2022-02-08 |
| 2020-09-30 | $29.12M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $28.13M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $28.62M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $29.06M 10-K · filed 2021-02-09 |
| 2019-09-30 | $29.69M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $30.35M 10-Q · filed 2019-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |